Dr. Hemangini Hasit Vora
Senior Scientific Officer

Email : hemangini.vora@gcriindia.org


Qualification : MSc, PhD
Designation : Senior Scientific Officer, Head Immunohistochemistry & Flow Cytometry Division
Specialization : Cancer Research
Experience (in yrs.) : 30 years   

Academic Achievements:
PhD Guiding Teacher and MSc Course Coordinator – Gujarat University

Awards& Achievements:
Dr. T.B. Patel Gold Medal awarded for Best Research Paper of 1992 entitled "Prolactin in advanced breast cancer An Indian experience" published in the journal "Breast Disease 1993".
Best Paper Award – First prize for oral research paper presentation entitled "Ectopic production of prolactin in advanced tongue cancer" in the year 1993 by Indian Association of Endocrinologists.
Travel Award – International Clinical Cytometry Society Travel Award to attend Course and Meeting of Clinical Cytometry Society, October 9-15, 2008

Publication:
No. of publication in State / National / International journal = 67

Training/Fellowship:
Summer Program on Basics in Electrophoresis Techniques at Electrophoresis Institute, Biotech-Yercaud, Yercaud, May 5-14, 2004.
Participated in “CME In Hematology 2007” held at Ahmedabad Management Association, March 18, 2007.
Participated as delegate in National Meeting on Guidelines for Immunophenotyping of Haematolymphoid Neoplasms and Workshop on analysis of Flowcytometric Data at Tata Memorial Hospital, Mumbai during March 13-15, 2008.
Summer Program on Basics in Electrophoresis Techniques at Electrophoresis Institute, Biotech-Yercaud, Yercaud, May 5-14, 2004.
International Clinical Cytometry Society Travel Award to attend Course and Meeting of Clinical Cytometry Society, October 9-15, 2008.
Attended Workshop on Advanced Clinical Applications of Flowcytometry organized by National Institute of Immunohematology, February 23-26, 2010.

Area of Interest:
The main areas of research include study of PI3K-AKT pathway, and EMT pathway in breast cancer. Moreover, evaluation of circulating tumor cells and cancer stem cells are evaluated by Flow Cytometry in breast cancer patients. Further, a project is proposed on molecules that influence cancer stem cell niche in breast cancer. Minimal Residual Disease is evaluated by flow cytometry and using molecular markers in B-ALL. EGFR downstream signaling pathway in non-smoker adenocarcinoma of lung and immune dysfunction in oral cancer are also being studied. Based on above research areas 7 research projects are ongoing in our division